Prescription drug · NDA
Syprine (Trientine hydrochloride) NDC 0187-2120
Trientine hydrochloride 250 mg/1 · Capsule · Oral · Bausch Health US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0187-2120-10 | 00187212010 | 1 BOTTLE in 1 CARTON (0187-2120-10) / 100 CAPSULE in 1 BOTTLEMarketed from Nov 8, 1985 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Syprine
- Generic name (nonproprietary)
- trientine hydrochloride
- Active ingredients
- Trientine hydrochloride — 250 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bausch Health US LLCNDC labeler code 0187
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019194
- Marketing start
- Listing expires
- Other FDA classes
- Metal Chelating Activity (Mechanism)
- Identifiers
- Product ID 0187-2120_38dd4547-62ef-4e2f-afc2-bfe43eb86b8dSPL ID 38dd4547-62ef-4e2f-afc2-bfe43eb86b8dSPL set ID c34f77a7-996b-4470-b5df-d946a7fe5dbeRxCUI 208720, 313472UNII HC3NX54582
- Pharmacologic class
- Metal Chelator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400187212010followed by a unit qualifier and the quantityPackage 00187-2120-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Syprine is indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine. Clinical experience with Syprine is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. Syprine and penicillamine cannot be considered interchangeable. Syprine should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. Unlike penicillamine, Syprine is not recommended in cystinuria or rheumatoid arthritis. The absence of a sulfhydryl moiety renders it incapable of binding cystine an…
Excerpt only. Read the full label for complete information.
About NDC 0187-2120
- What is NDC 0187-2120?
- 0187-2120 is the product NDC for Syprine (trientine hydrochloride), Trientine hydrochloride 250 mg/1 capsule, listed with the FDA by Bausch Health US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Syprine (Trientine hydrochloride).
- What is the active ingredient?
- Trientine hydrochloride.
- Who is the labeler?
- Bausch Health US LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Syprine?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.